Gam-COVID-Vac or Sputnik V results published in Lancet User Ford_Martin, in the ConservativeKiwi subreddit, 07 Sep 2020
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia User indolgofera, in the Reddit Science subreddit, 04 Sep 2020
Finalmente! Artigo do estudo de fase 1/2 da Sputnik V no The Lancet hoje: Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two form ulations: two open, non-randomised phase 1/2 studies from Russia User pedceron, in the [ARQUIVADO] Coronavírus Brasil (COVID-19) subreddit, 04 Sep 2020
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia User smaskens, in the COVID-19 subreddit, 04 Sep 2020
Russia’s vector-based COVID-19 vaccine has a good safety profile and induced strong humoral and cellular immune responses in participants, finds new phase 1/2 studies published today. (Lancet, 4 September 2020) User mvea, in the Reddit Science subreddit, 04 Sep 2020